<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosomal translocation and subsequent de-regulation of the c-myc proto-oncogene are considered to be critical events in the multi-stage evolution of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>It is widely accepted that Myc protein functions as a competence factor for proliferation </plain></SENT>
<SENT sid="2" pm="."><plain>However, recent studies indicate that it can also act in some cell types as a regulator of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell populations display a high frequency of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in vivo, a property which is also readily demonstrable in vitro in group I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>Such lines are known to retain the cell surface marker characteristics of the parental <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells and, in the case of Epstein-Barr virus-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, their restricted <z:mp ids='MP_0001799'>viral</z:mp> protein expression </plain></SENT>
<SENT sid="5" pm="."><plain>We have shown previously that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a group I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell line is inhibited by interferon (IFN)-alpha </plain></SENT>
<SENT sid="6" pm="."><plain>Here we show that IFN-alpha-mediated suppression of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in group I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells corresponds temporally with inhibition of Myc protein levels </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, inhibition of Myc expression following treatment with c-myc anti-sense oligonucleotides markedly enhanced survival of group I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that, whilst c-myc may facilitate cycling of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in which it is de-regulated, it also stimulates their <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>